Literature DB >> 8630349

Thrombogenicity of the human arterial wall after interventional thermal injury.

M J Post1, A N de Graaf-Bos, H G van Zanten, P G de Groot, J J Sixma, C Borst.   

Abstract

Thermal injury has been shown to reduce platelet adhesion (PA) in vitro but not in vivo. The controversy may be based on the mode of thermal injury, the anticoagulation regimen, or species differences. Human and rabbit arteries were dilated by a radio-frequency (RF)-heated balloon (RF dilation) or by immersion in heated buffer. The artery segments were perfused in an annular perfusion chamber with blood anticoagulant by citrate or heparin (37 degrees C, 5 min, shear rate: 1,300 s-1). To determine PA to deep wall layers, 6-micron cross-sections of heated arteries were perfused in a rectangular perfusion chamber (37 degrees C, 5 min, 1,300 s-1). After RF dilation of human arteries at 55 and 90 degrees C, subendothelical PA (citrated blood) decreased from 28.9% at 37 degrees C to 6.8%, and increased to 39.6%, respectively (in both cases p<0.05). Heparin anticoagulation resulted in subendothelial fibrin deposition that was equal after 37 and 90 degrees C, and decreased after 55 degrees C. Heating of cross-sections of atherosclerotic coronary arteries to 55 and 90 degrees C, showed increased and decreased PA, respectively, to the intima and media. No effect was observed on the highly reactive adventitia and atherosclerotic plaque. We conclude that thermal balloon angioplasty at 90 degrees C reduces PA to the arterial subendothelium, but not to the adventitia or the atherosclerotic plaque. As thermal balloon angioplasty in patients will always produce a region with increased PA at 55 degrees C and as heparin anticoagulation permits fibrin deposition that is not affected by heat, it is unlikely that thermal balloon angioplasty alone will reduce thrombotic complications.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8630349     DOI: 10.1159/000159144

Source DB:  PubMed          Journal:  J Vasc Res        ISSN: 1018-1172            Impact factor:   1.934


  4 in total

Review 1.  Bioresorbable Scaffolds: Current Evidences in the Treatment of Coronary Artery Disease.

Authors:  Bhargav Dave
Journal:  J Clin Diagn Res       Date:  2016-10-01

Review 2.  Bioresorbable scaffolds: current evidence and ongoing clinical trials.

Authors:  Christos V Bourantas; Yaojun Zhang; Vasim Farooq; Hector M Garcia-Garcia; Yoshinobu Onuma; Patrick W Serruys
Journal:  Curr Cardiol Rep       Date:  2012-10       Impact factor: 2.931

3.  Airway smooth muscle as a target in asthma and the beneficial effects of bronchial thermoplasty.

Authors:  Luke J Janssen
Journal:  J Allergy (Cairo)       Date:  2012-09-16

Review 4.  Vascular restoration therapy and bioresorbable vascular scaffold.

Authors:  Yunbing Wang; Xingdong Zhang
Journal:  Regen Biomater       Date:  2014-10-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.